Mean plasma levels of stem cell growth factor beta (SCGF beta) and hepatocyte growth factor (HGF) were found to be significantly increased in CD and DCM patients with advanced HF (NYHA III-IV) compared to control group [17,18]. Here, HGF is linked to hydrops fetalis.